Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

<div>Kaplan-Meier curves for overall survival of NSCLC patients. (a) Expression of NeuGcGM3. (b) Dual expression of NeuGcGM3 and EGFR. (c) Double expression of NeuGcGM3 and EGF. (d) Triple expression of NeuGcGM3, EGFR, and EGF. Statistical analysis by log-rank test.</div>

Pathology Research International

fig4

Figure 4

Figure 4: Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences 